294 related articles for article (PubMed ID: 21440067)
1. Decreased expression of GGA3 protein in Alzheimer's disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein.
Santosa C; Rasche S; Barakat A; Bellingham SA; Ho M; Tan J; Hill AF; Masters CL; McLean C; Evin G
Neurobiol Dis; 2011 Jul; 43(1):176-83. PubMed ID: 21440067
[TBL] [Abstract][Full Text] [Related]
2. Caspase-3 cleavage of GGA3 stabilizes BACE: implications for Alzheimer's disease.
Vassar R
Neuron; 2007 Jun; 54(5):671-3. PubMed ID: 17553417
[TBL] [Abstract][Full Text] [Related]
3. Elucidation of the BACE1 regulating factor GGA3 in Alzheimer's disease.
Natunen T; Parrado AR; Helisalmi S; Pursiheimo JP; Sarajärvi T; Mäkinen P; Kurkinen KM; Mullin K; Alafuzoff I; Haapasalo A; Bertram L; Soininen H; Tanzi RE; Hiltunen M
J Alzheimers Dis; 2013; 37(1):217-32. PubMed ID: 23970038
[TBL] [Abstract][Full Text] [Related]
4. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
5. Β-site APP-cleaving enzyme 1 trafficking and Alzheimer's disease pathogenesis.
Tan J; Evin G
J Neurochem; 2012 Mar; 120(6):869-80. PubMed ID: 22171895
[TBL] [Abstract][Full Text] [Related]
6. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
7. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.
Tesco G; Koh YH; Kang EL; Cameron AN; Das S; Sena-Esteves M; Hiltunen M; Yang SH; Zhong Z; Shen Y; Simpkins JW; Tanzi RE
Neuron; 2007 Jun; 54(5):721-37. PubMed ID: 17553422
[TBL] [Abstract][Full Text] [Related]
8. Retromers in Alzheimer's disease.
Siegenthaler BM; Rajendran L
Neurodegener Dis; 2012; 10(1-4):116-21. PubMed ID: 22398391
[TBL] [Abstract][Full Text] [Related]
9. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice.
Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL
Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100
[TBL] [Abstract][Full Text] [Related]
10. Expression of APP pathway mRNAs and proteins in Alzheimer's disease.
Matsui T; Ingelsson M; Fukumoto H; Ramasamy K; Kowa H; Frosch MP; Irizarry MC; Hyman BT
Brain Res; 2007 Aug; 1161():116-23. PubMed ID: 17586478
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide reduces mRNA and protein levels of β-site amyloid precursor protein cleaving enzyme 1 in PC12 cells.
Zhang H; Gao Y; Zhao F; Dai Z; Meng T; Tu S; Yan Y
Neurochem Int; 2011 Feb; 58(2):169-75. PubMed ID: 21095213
[TBL] [Abstract][Full Text] [Related]
12. A novel beta-site amyloid precursor protein cleaving enzyme (BACE) isoform regulated by nonsense-mediated mRNA decay and proteasome-dependent degradation.
Tanahashi H; Tabira T
Neurosci Lett; 2007 Nov; 428(2-3):103-8. PubMed ID: 17961921
[TBL] [Abstract][Full Text] [Related]
13. BACE (beta-secretase) modulates the processing of APLP2 in vivo.
Pastorino L; Ikin AF; Lamprianou S; Vacaresse N; Revelli JP; Platt K; Paganetti P; Mathews PM; Harroch S; Buxbaum JD
Mol Cell Neurosci; 2004 Apr; 25(4):642-9. PubMed ID: 15080893
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
[TBL] [Abstract][Full Text] [Related]
15. Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?
Nawrot B
Acta Biochim Pol; 2004; 51(2):431-44. PubMed ID: 15218540
[TBL] [Abstract][Full Text] [Related]
16. GGA1-mediated endocytic traffic of LR11/SorLA alters APP intracellular distribution and amyloid-β production.
Herskowitz JH; Offe K; Deshpande A; Kahn RA; Levey AI; Lah JJ
Mol Biol Cell; 2012 Jul; 23(14):2645-57. PubMed ID: 22621900
[TBL] [Abstract][Full Text] [Related]
17. BACE: Therapeutic target and potential biomarker for Alzheimer's disease.
Evin G; Barakat A; Masters CL
Int J Biochem Cell Biol; 2010 Dec; 42(12):1923-6. PubMed ID: 20817005
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
[TBL] [Abstract][Full Text] [Related]
19. The Golgi-Localized γ-Ear-Containing ARF-Binding (GGA) Proteins Alter Amyloid-β Precursor Protein (APP) Processing through Interaction of Their GAE Domain with the Beta-Site APP Cleaving Enzyme 1 (BACE1).
von Einem B; Wahler A; Schips T; Serrano-Pozo A; Proepper C; Boeckers TM; Rueck A; Wirth T; Hyman BT; Danzer KM; Thal DR; von Arnim CA
PLoS One; 2015; 10(6):e0129047. PubMed ID: 26053850
[TBL] [Abstract][Full Text] [Related]
20. Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease.
Leuba G; Wernli G; Vernay A; Kraftsik R; Mohajeri MH; Saini KD
Dement Geriatr Cogn Disord; 2005; 19(4):171-83. PubMed ID: 15677864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
